PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations
Clicks: 153
ID: 267053
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.4
/100
153 views
25 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #13 of 13 articles by views in Cell death & disease
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Somatic activating mutations within the PIK3CA gene have been recently detected in sporadic lymphatic and venous malformations, and in vascular malformations (VM) associated to overgrowth syndromes, such as CLOVES and Klippel–Trenaunay syndrome. ...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (34 words).
Try re-searching for a better abstract.
| Reference Key |
primo2018cellpi3k/mtor
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Laura di Blasio, Alberto Puliafito, Paolo Armando Gagliardi, Valentina Comunanza, Desiana Somale, Giulia Chiaverina, Federico Bussolino, Luca Primo;Laura di Blasio;Alberto Puliafito;Paolo Armando Gagliardi;Valentina Comunanza;Desiana Somale;Giulia Chiaverina;Federico Bussolino;Luca Primo; |
| Journal | Cell death & disease |
| Year | 2018 |
| DOI |
10.1038/s41419-017-0064-x
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.